Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06992843 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neuroprotection Bundles For Comatose Survivors Following Cardiac Arrest

Study acronym: LAPTOPS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2025 to Oct 22, 2025
    • Site details revised
    • Study title shortened, about 1 word
    v4
  2. Secondary endpoints: details revised at 3 of 12 entriesv3
  3. Start date: May 2025 to Sep 2025v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators designed LAPTOPS to determine the effectiveness of a goal-directed neuroprotection bundles of active management including body temperature,PaCO2,PaO2,position,Blood glucose ,blood sodium,Blood pressure and Lactate vs. usual care in adult post-cardiac arrest care. LAPTOPS is a large-scale pragmatic clinical trial to provide reliable evidence over the effectiveness of a widely applicable goal-directed care bundle in acute phase of adult post-cardiac arrest care.
Trial Details
NCT Number NCT06992843
Lead Sponsor Xiangya Hospital of Central South University
Conditions
(from sponsor)		 Cardiac Arrest, Post-cardiac Arrest Care
Related terms Heart Arrest
Enrollment 1,008 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov